Response to Krieger et al. re: "tSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746-747)

T.J. Smith (Terry) and Janssen, J.A.M.J.L. (Joseph A.M.J.L.)

2017-11-01

Thyroid , Volume 27 - Issue 11 p. 1458- 1459

Additional Metadata
Persistent URL	doi.org/10.1089/thy.2017.0281, hdl.handle.net/1765/102752
Journal	Thyroid
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Smith, T., & Janssen, J.A.M.J.L. (Joseph A.M.J.L.). (2017). Response to Krieger et al. re: "tSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746-747). Thyroid, 27(11), 1458–1459. doi:10.1089/thy.2017.0281

Publication